CTI Biopharma (Formerly Cell Therapeutics)
CTI BioPharma | Seeking to Bring New Options to Patients with Blood Cancers.
Launch date
Employees
Market cap
CAD1.6b
Enterprise valuation
CAD1.6b (Public information from Jul 2023)
Share price
$9.09 CTIC
Seattle Washington (HQ)
Authorizing premium user...